Investigation the effects of Arctium Lappa root powder in women with polycystic ovary syndrome
Phase 2
- Conditions
- Polycystic ovary syndrome.Polycystic ovarian syndromeE28.2
- Registration Number
- IRCT20230222057492N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Women in the age range of 18-45 years
Confirmation of PCOS by a specialist doctor
Patient satisfaction to enter the study
Patients who do not intend to become pregnant because the profile of therapeutic drugs for people who intend to become pregnant is different from those who do not intend to become pregnant
Exclusion Criteria
Smoking
consumption of anticoagulant drugs and antioxidant and anti-inflammatory supplements for 3 months before the study.
Pregnancy
Breastfeeding
Diabetes
Thyroid disorders
Hyperprolactinemia
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method